FDA updates labeling for MS CONTIN FDA Approval Dec. 31, 2025, 13:45 UTC 17 0 comments Labeling changes approved for PURDUE PHARMA LP. Active ingredient: MORPHINE SULFATE. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for ALFENTA FDA Approval Dec. 31, 2025, 13:45 UTC 26 0 comments Labeling changes approved for RISING. Active ingredient: ALFENTANIL HYDROCHLORIDE. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for DILAUDID FDA Approval Dec. 31, 2025, 13:45 UTC 22 0 comments Labeling changes approved for RHODES PHARMS. Active ingredient: HYDROMORPHONE HYDROCHLORIDE. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for FENTANYL CITRATE FDA Approval Dec. 31, 2025, 13:45 UTC 22 0 comments Labeling changes approved for HIKMA. Active ingredient: FENTANYL CITRATE. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for FENTANYL CITRATE FDA Approval Dec. 31, 2025, 13:45 UTC 21 0 comments Labeling changes approved for HOSPIRA. Active ingredient: FENTANYL CITRATE. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for SUFENTA PRESERVATIVE FREE FDA Approval Dec. 31, 2025, 13:45 UTC 20 0 comments Labeling changes approved for RISING. Active ingredient: SUFENTANIL CITRATE. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for DILAUDID FDA Approval Dec. 31, 2025, 13:45 UTC 22 0 comments Labeling changes approved for RHODES PHARMS. Active ingredient: HYDROMORPHONE HYDROCHLORIDE. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for MEPERIDINE HYDROCHLORIDE FDA Approval Dec. 31, 2025, 13:45 UTC 21 0 comments Labeling changes approved for EPIC PHARMA LLC. Active ingredient: MEPERIDINE HYDROCHLORIDE. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for HYDROCODONE BITARTRATE AND ACETAMINOPHEN FDA Approval Dec. 31, 2025, 13:45 UTC 19 0 comments Labeling changes approved for CHARTWELL. Active ingredient: ACETAMINOPHEN; HYDROCODONE BITARTRATE. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for HYDROCODONE BITARTRATE AND ACETAMINOPHEN FDA Approval Dec. 31, 2025, 13:45 UTC 26 0 comments Labeling changes approved for PHARM ASSOC. Active ingredient: ACETAMINOPHEN; HYDROCODONE BITARTRATE. Decision date: 12/22/2025 Comment Full text